Kadis Bio

River BioMedics

This company develops small molecule therapies and human cardiac in vitro models for pharmaceutical companies and researchers to treat cardiac diseases.

RadaHaim

This company provides scalable organoid mass production platforms and research services to pharmaceutical firms and clinicians for drug discovery and toxicity screening.

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

iOrganBio

This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.

ReproGo

This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.

Kardigan

This company develops precision cardiovascular medicines and a clinical intelligence platform for patients with heart diseases such as dilated cardiomyopathy and hypertension.

Cardiatech Bio

The company develops a computational platform to discover cardiovascular drug targets using multi-omics data for the pharmaceutical and biotechnology industries.